Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab

References

Page 1

	Year	Citations
Case report 2 J R Von Ronnen Skeletal Radiology Clinical Case ReportLawCriminal LawCase AnalysisCase Report 2	1976	805
Interferon Beta Treatment in Neuromyelitis Optica Jacqueline Palace, Maria Isabel Leite, Angela Nairne, Archives of Neurology	2010	321
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica Ingo Kleiter Archives of Neurology	2012	293
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder Ju‐Hong Min, Byoung Joon Kim, Kwang Ho Lee Multiple Sclerosis Journal Extensive Brain LesionsOphthalmologySclerodermaMedicineNeurological Disorder	2011	282
Cognitive impairment and cortical degeneration in neuromyelitis optica Etsuji Saji, Musashi Arakawa, Kaori Yanagawa, Annals of Neurology	2012	167
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients Liene Elsone, Jay Panicker, Kerry Mutch, Multiple Sclerosis Journal Ocular DiseaseIntravenous ImmunoglobulinImmunodeficienciesImmunologyIntravenous Immunoglobulins	2013	142
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells Pia Kivisäkk, Barry Healy, Vissia Viglietta, Neurology	2009	141
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy JW Prineas, ME Buckland, JDE Parratt, Multiple Sclerosis Journal Ocular DiseaseNeurological DisorderImmunologyAstrocyte InjuryOptic Nerve	2011	121
Cognitive Functions in Neuromyelitis Optica Frédéric Blanc, Hélène Zéphir, Christine Lebrun‐Frénay, Archives of Neurology	2008	120
White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica Frédéric Blanc, Vincent Noblet, Barbara Jung, PLoS ONE NeuropsychologyNeurological DisorderWhite MatterBrain LesionWhite Matter Atrophy	2012	106

Page 1